Li-at Zeltzer

Locally produced CD19 CAR T cells leading to clinical remissions in medullary and extramedullary relapsed acute lymphoblastic leukemia

J. Schachter, A. Nagler, A. Toren, 2018, American journal of hematology.

Comprehensive single institute experience with melanoma TIL: Long term clinical results, toxicity profile, and prognostic factors of response

J. Schachter, A. Nagler, G. Markel, 2020, Molecular carcinogenesis.

Head-to-head comparison of in-house produced CD19 CAR-T cell in ALL and NHL patients

J. Schachter, A. Nagler, A. Toren, 2020, Journal for ImmunoTherapy of Cancer.

Impact of cryopreservation on CAR T production and clinical response

M. Besser, A. Kubi, E. Jacoby, 2022, Frontiers in Oncology.

Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapy

E. Fridman, J. Schachter, Sharon Yunger, 2019, Oncoimmunology.

Molecular and Functional Signatures Associated with CAR T Cell Exhaustion and Impaired Clinical Response in Patients with B Cell Malignancies

J. Schachter, A. Nagler, A. Toren, 2022, Cells.

Modeling Peripartum Cardiomyopathy With Human Induced Pluripotent Stem Cells Reveals Distinctive Abnormal Function of Cardiomyocytes.

J. Leor, L. Monserrat, M. Arad, 2018, Circulation.